Skip to content
refer tinnitus patients to Lenire

Help tinnitus patients access a treatment option that works.

  • Lenire is proven in trials, confirmed in the real world.
  • Rated the safest, most effective treatment option by the American Tinnitus Assoc. and Tinnitus UK.
  • Patients use non-invasive Lenire from the comfort of their own home.
  • 91.5% of patients had relief after treatment with Lenire at an independent clinic.
  • Patients receive ongoing treatment guidance from a tinnitus expert.

FAQs for Referring Healthcare Professionals

  • Where Can I Refer to a Lenire Provider?

    Lenire is available through certified hearing care professionals with tinnitus expertise in the United Kingdom, Europe, and the USA. You can find a clinic to refer your patients to using Lenire’s Interactive Clinic Map.

  • Are Tinnitus Patients Satisfied with Lenire?

    83% of Lenire’s clinical trial participants would recommend Lenire to treat tinnitus. This is a strong indicator of Lenire’s efficacy and patient satisfaction.1

    Lenire Partners are selected based on the expertise in treating tinnitus patients. So, in addition to the groundbreaking at-home tinnitus treatment device, your patients benefit from the best possible care for tinnitus patients available.

  • How Will Referring Lenire Support My Clinic?

    Healthcare professionals who have access to Lenire’s network of tinnitus care experts can offer their patients the best possible treatment options guided by industry-leading expertise.

    • Confidence in Care: 15% of the global adult population is living with tinnitus. Understanding tinnitus and tinnitus treatment options increases tinnitus patient satisfaction.
    • Support Ageing Patients: Tinnitus disproportionately people of retired age due to age-related hearing loss. As your patient base ages, understanding the latest treatment options for tinnitus will help your clinic continue to support your patients as they age.
    • Reduce Recurring Visits: Tinnitus patients have complex needs that often go beyond treatment options. As a result, healthcare professionals will often see tinnitus patients more than once. Referring tinnitus patients to an expert-led treatment pathway offers them relief while reducing recurring visits for single issues.

    If you’re are deciding where to refer tinnitus patients, Lenire’s network of expert tinnitus clinics will ensure that your patients receive the best care and the latest evidence-based treatment options.

  • Is Lenire an Effective Tinnitus Treatment?

    Lenire’s bimodal neurmodulation is proven to be an effective tinnitus treatment. Clinical trial data and real world evidence support Lenire’s effectiveness.

    • TENT-A1 Clinical Trial: 80% of patients experienced a significant reduction in tinnitus severity that sustained for at least 12 months. 
    • TENT-A2 Clinical Trial: 91% of patients reported a significant reduction that sustained for at least 12-months. 
    • Controlled TENT‑A3 Trial: 70% of patients with moderate or worse tinnitus achieved clinically meaningful improvement with Lenire, compared to minimal changes with sound-only therapy. Sound-therapy was TENT-A3’s control.
    • Peer-Reviewed Real World Data: 220 patients showed that 91.5% had significant relief after 12 weeks of treatment.  This is consistent with clinical trials.

    Patients typically use Lenire at home for two 30-minute sessions per day, for a period recommended by their qualified audiologist. Lenire’s unique bimodal neuromodulation approach – combining auditory stimulation with gentle electrical stimulation of the tongue – leverages neuroplasticity to retrain the brain’s response to tinnitus.